NCT03987113View on ClinicalTrials.gov

Impact of Cold Ischemia on Pulmonary Endothelial Dysfunction in Ex-vivo Pulmonary Reconditioning

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

November 15, 2018

Primary Completion Date

October 30, 2019

Study Completion Date

October 30, 2019

Conditions
Lung Transplant
Interventions
OTHER

Plasma concentration analysis during and after ex-vivo pulmonary reconditioning

The pulmonary endothelial dysfunction will be evaluated with plasma concentration of heparan sulphate, syndecan-1, endothelin-1 and i-NOS.

Trial Locations (1)

92150

Hôpital Foch, Suresnes

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale Rouen U1096

UNKNOWN

lead

Hopital Foch

OTHER

NCT03987113 - Impact of Cold Ischemia on Pulmonary Endothelial Dysfunction in Ex-vivo Pulmonary Reconditioning | Biotech Hunter | Biotech Hunter